Notice is hereby given that an Extraordinary General Meeting of Shareholders of BPH Global Limited ACN 009 104 330 will be held at 3:00pm AEST on 24 May 2024 at Suite 5, Level 12, 530 Collins Street, Melbourne VIC 3000 (Meeting). The Explanatory Statement to this Notice of Meeting provides additional information on matters to be considered at the Extraordinary General Meeting. The Explanatory Statement and the Proxy Form forms part of this Notice of Meeting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vo ..read more

Several Republican Party members have sent a letter to the US Drug Enforcement Administration (DEA) urging it to reject the US Department of Health and Human Services' recommendation to reschedule cannabis. Meanwhile, the DEA spoke publicly about the rescheduling process for the first time, and lawmakers in New Hampshire voted to reject a proposed amendment to a cannabis legalization bill, putting its future in the Senate in doubt. Stay up to date on the latest news, trends and policy developments in the cannabis industry with our round-up below. DEA addresses cannabis rescheduling timeline ..read more

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that its wholly owned Australian subsidiary, Health House Australia, continues to make strong operational progress. Highlights: Health House Australia announces the planned launch of its medicinal cannabis clinic in Q2 of 2024 The group is also pleased to announce that it has added several new suppliers during Q1 of 2024 Health House Australia was a key contributor to Melodiol group FY 2023 revenues of $21.6m (an increase of 148% on FY 2022) Health House Australia and Health House UK contributed $11 ..read more

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) investigating new treatments for mental health and select neurological conditions, is pleased to announce it has entered into a binding research study agreement with charity Reach Wellness to manage a pivotal observational study designed to evaluate the effectiveness of Emyria’s MDMA-assisted therapy (MDMA-AT) program, together with a support program managed by Reach Wellness, for first responders with PTSD. The agreement underscores Emyria's leadership in the evolving field of MDMA-AT research and marks a significant step forward in add ..read more

The Board of BPH Global Ltd (ASX: BP8) (Company) announces that the Company’s CEO Matthew Leonard and CFO Chow Yee Koh are currently travelling in Malaysia and China for a series of meetings over a 2–3- week period commencing last week. The CEO and CFO will be joined by China-based Company Director Michael Huang for strategic meetings in Malaysia and China. Highlights CEO & CFO in Malaysia & China to advance BP8’s APAC & China-based projects as part of a 120- day business plan. Wide and deep engagement with potential China-based cornerstone investors. Focus on securing supply ag ..read more

After years of lobbying, the Canadian federal government took an important step that may soon result in a reduction to the high excise tax rates paid on cannabis products. Meanwhile, the University of British Columbia is embarking on a new clinical study that looks into the effects cannabidiol (CBD) may have on the symptoms of bipolar depression, and Verano Holdings (OTCQX:VRNOF) reported good news for shareholders. Stay up to date on the latest news, trends and policy developments in the cannabis industry with our round-up below. House of Commons committee calls for cannabis tax change ..read more

The Board of BPH Global Ltd (ASX: BP8) (Company) is pleased to announce that the Company is expanding the nature of its business to include the following projects: Essential mineral extraction: The Company’s extraction of individual macro minerals and micro minerals from seaweed and sea plant biomass, to enable the sale of those macro and micro minerals to the commodities markets, and to industry specific markets such as the battery industry, and thereby create an additional revenue stream for the Company; and Seaweed and Blue Carbon Credits: The Company’s sale of seaweed cellulose fibre as ..read more

Cannabis company Blüm Holdings (OTCQB:BLMH) signed a letter of intent to purchase three California retail locations from Operators Only this week in a bid to expand its business into Sacramento. Meanwhile, Ukraine passed legislation to legalize medical cannabis use, and Québec's only cannabis retailer reported its results for the third quarter of 2023, showing sales growth. Also, after years of trying to establish an adult-use cannabis market, Virginia's Senate and the House of Delegates approved two separate cannabis sales bills. Stay up to date on the latest news, trends and policy develop ..read more

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to present its Preliminary Final Year Report. PRELIMINARY FINAL REPORT For the year ended 31 December 2023, previous corresponding period is 31 December 2022. CHANGE OF COMPANY NAME On 31 May 2023, the Company announced that at the Annual General Meeting held on that date a resolution was passed by shareholders to change the Company’s name from Creso Pharma Limited (ASX: CPH) to Melodiol Global Health Limited (ASX: ME1). The change of name took effect on ASX from the commencement of trading on 13 June 2023 RESU ..read more

BPH Global Ltd (ASX: BP8) (Company) is pleased to present its Half Year Report. Click here for the full ASX Release This article includes content from BPH Global Ltd, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here ..read more